Observational studies can play a useful role in assessing the comparative effectiveness of competing treatments. In a clinical trial the randomization of participants to treatment and control groups generally results in well-balanced groups with respect to possible confounders, which makes the analysis straightforward. However, when analysing observational data, the potential for unmeasured confounding makes comparing treatment effects much more challenging. Causal inference methods such as Instrumental Variable and Prior Even Rate Ratio approaches make it possible to circumvent the need to adjust for confounding factors that have not been measured in the data or measured with error. Direct confounder adjustment via multivariable regression and Propensity score matching also have considerable utility. Each method relies on a different set of assumptions and leverages different aspects of the data. In this paper, we describe the assumptions of each method and assess the impact of violating these assumptions in a simulation study. We propose the prior outcome augmented Instrumental Variable method that leverages data from before and after treatment initiation, and is robust to the violation of key assumptions. Finally, we propose the use of a heterogeneity statistic to decide if two or more estimates are statistically similar, taking into account their correlation. We illustrate our causal framework to assess the risk of genital infection in patients prescribed Sodium-glucose co-transporter-2 inhibitors versus Dipeptidyl peptidase-4 inhibitors as second-line treatment for Type 2 Diabets using observational data from the Clinical Practice Research Datalink.
翻译:在临床试验中,将参与者随机安排到治疗和控制组群中,通常会导致与可能的折叠者相比,使分析简单明了。然而,在分析观察数据时,可能无法计量的折叠使比较治疗效果更加具有挑战性。工具变量和前均均匀比率等因果推论方法可以绕过调整数据中未计量或计量误差的混混因素的需要。通过多变回归和分数匹配进行直接的折叠调整,也具有相当大的效用。每种方法都依赖不同的假设并利用数据的不同方面。在本文件中,我们描述每种方法的假设,并在模拟研究中评估违反这些假设的影响。我们建议先前的结果增强工具变量方法,在治疗开始之前和之后利用数据,并与关键假设相适应。最后,我们提议使用高遗传性统计性统计性统计来决定两种或更多种或多种种次的生殖系统分数,在统计性分析中用两种或更多种血压变压的生殖系统变压模型来评估其因果关系。